Company research / SCND

Scientific Industries Inc (SCND)

SEC name SCIENTIFIC INDUSTRIES INC · CIK 0000087802 · OTC · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends around Dec 31

For the year ended 2025-12-31, Scientific Industries Inc reported revenue of $5.05M. Revenue grew 5.4% from the prior annual period.

Key ratios (year ended 2025-12-31)

25.8%
Gross margin
-156.1%
Operating margin
-24.1%
Net margin
-11.4%
Return on year-end equity
5.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenuen/a$5.05M$4.80M$11.11Mn/a$11.40M$9.78M$7.78M$10.20M$8.48M$8.15M
Cost of Revenuen/a$3.75M$2.79M$6.01Mn/a$5.66M$4.80M$3.85M$5.83M$5.26M$5.27M
Gross Profitn/a$1.30M$2.01M$5.10Mn/a$5.74M$4.98M$3.94M$4.37M$3.22M$2.88M
R&D Expensen/a$2.49M$2.90M$3.57Mn/a$2.87M$1.62M$1.14M$530.5K$520.9K$437.5K
Operating Incomen/a-$7.89M-$8.22M-$9.26Mn/a-$11.54M-$4.71M-$663.5K$776.1K-$5.5K-$160.4K
Depreciation & Amortization$395.1K$610.0K$750.7K$754.0Kn/a$688.2K$251.5K$160.9K$257.3K$305.1K$355.9K
EBITDAn/a-$7.28M-$7.47M-$8.51Mn/a-$10.86M-$4.46M-$502.6K$1.03M$299.6K$195.5K
Net Income-$741.3K-$1.22M-$6.45M-$9.09Mn/a-$13.67M-$3.67M-$703.3K$645.6K-$160.5K-$72.6K
EPS (Diluted)n/a-$0.11-$0.61-$1.27n/an/a-$1.00-$0.46$0.43-$0.11-$0.05
Total Assets$10.11M$12.61M$11.56M$16.73M$18.07M$21.01M$29.01M$14.80M$8.28M$7.33M$6.83M
Total Liabilities$2.03M$1.94M$2.44M$2.85M$3.28M$3.47M$2.78M$3.08M$1.94M$1.62M$999.7K
Long-Term Debtn/an/an/an/an/an/an/an/an/a$0$5.8K
Shareholders' Equity$8.07M$10.66M$9.12M$13.89M$14.79M$17.54M$26.22M$11.72M$6.34M$5.70M$5.83M
Cash & Equivalentsn/an/an/an/a$1.93M$2.97M$9.68M$7.56M$1.60M$1.05M$1.03M
Operating Cash Flown/a-$8.15M-$3.05Mn/an/an/an/an/an/an/an/a
Capital Expenditures$44.5K$63.2K$98.9K$131.7Kn/a$757.6K$198.7K$50.9K$187.8K$61.4K$17.0K
Free Cash Flown/a-$8.21M-$3.15Mn/an/an/an/an/an/an/an/a
Shares Outstanding11.93M11.93M10.50M10.15M7.00M7.00M6.46M2.86M1.49M1.51M1.51M
Weighted Average Diluted Sharesn/a11.34M10.50M10.15Mn/a6.64M3.19M1.52M1.51M1.49M1.49M
EPS (Basic)n/an/an/an/an/an/a-$1.00-$0.46$0.43-$0.11-$0.05